Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
PRESS RELEASES
Novus Therapeutics Appoints June Lee, M.D., To Board Of Directors
By Business Wire
Dec 9, 2020 8:30 AM EST
PRESS RELEASES
Novus Therapeutics Announces First Patient Enrolled In Phase 2a Clinical Trial Of Anti-CD40L Antibody AT-1501 In Amyotrophic Lateral Sclerosis
By Business Wire
Nov 2, 2020 8:00 AM EST
PRESS RELEASES
Novus Therapeutics Announces One-for-Eighteen Reverse Stock Split
By Business Wire
Oct 2, 2020 11:00 AM EDT
PRESS RELEASES
Novus Therapeutics Announces Acquisition Of Anelixis Therapeutics
By Business Wire
Sep 14, 2020 4:31 PM EDT
PRESS RELEASES
Novus Therapeutics Completes Enrollment Of Phase 2a Trial Of OP0201 In Pediatric Patients With Acute Otitis Media
By Business Wire
Mar 2, 2020 6:30 AM EST
PRESS RELEASES
Novus Therapeutics Announces Exercise Of Warrants For $4.7 Million Gross Proceeds
By Business Wire
Jan 10, 2020 5:19 PM EST
